Rachel Ann Leonard

Rachel Leonard practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Rachel Leonard's NPI, 1356609465, was assigned on April 26, 2012. Rachel Leonard holds West Virginia license 25926.

Rachel Leonard's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Rachel Leonard's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Rachel Leonard is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University Health Associates. Dmand AI also links Rachel Leonard to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rachel Leonard practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Rachel Leonard's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Rachel Leonard is licensed in West Virginia.

CMS data shows 695 Medicare services from Rachel Leonard across 11 procedure codes in 2024, for 353 Medicare patients. Medicare paid $50,712 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 353 Medicare patients who saw Rachel Leonard in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rachel Leonard's median patient age at 70, with 46% women.

In 2024, Rachel Leonard wrote 1,002 Medicare Part D claims for 131 patients. 54% of them were for generic drugs. CMS names the drug for 885 of them, across 27 drugs with 11 or more claims each, at $331,143 in total drug cost. In 2023, CMS named 515 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Rachel Leonard for performance year 2024, reported through an alternative payment model (APM). Rachel Leonard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rachel Leonard as offering telehealth.

Dmand AI links 9 papers to Rachel Leonard, published from 2015 to 2023. 2020 was the busiest year, with 2. Rachel Leonard's most frequent co-authors are Haroon Ahmed, MD, Kyle Davis Chapman, MD and Michael Forte, MD.

CMS Open Payments shows 31 general payments to Rachel Leonard from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 53% of the total. Pulmonx Corporation paid the most, $1,933.